Skip to main content

Table 1 Characteristics of patients with early rheumatoid arthritis (RA) and healthy controls (HC)

From: MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis

  Early RA HC
Number 58    54
Sex, female/male, n 42/16    41/13
Age, years 54.93 ± 16.18    50.87 ± 15.11
Disease duration <6 months    
Treatment after 3 months     
 Glucocorticoids 46    
 Methotrexate 49    
 Leflunomide 1    
 Sulfasalazine 4    
 Hydroxychloroquine 2    
Clinical characteristic Baseline 3 months 6 months  
 RF IgM positivity, % 52 NA NA NA
 Anti-CCP positivity, % 66 NA NA NA
 DAS28 5.56 ± 1.56 3.05 ± 1.42 2.86 ± 1.25 NA
 CRP, mg/l 9.16 (0.30, 152.20) 3.10 (0.21, 23.85) 2.83 (0.24, 44.44) 1.02 (0.22, 4.36)
 ESR, mm/h 27.00 (4.00, 107.00) 15.50 (2.00, 54.00) 14.00 (2.00, 74.00) NA
  1. Data are expressed as the mean ± SD or median (range) according to the distribution. Anti-CCP anti-citrullinated antibodies, CRP C-reactive protein, DAS28 disease activity score, ESR erythrocyte sedimentation rate, HC healthy controls, NA not analyzed, RF rheumatoid factor